Cartesian Therapeutics, Inc. logo RNAC - Cartesian Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 8
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $20.50 DETAILS
HIGH: $25.00
LOW: $16.00
MEDIAN: $20.50
CONSENSUS: $20.50
UPSIDE: 115.56%

Profitability Ratios

Ratio Value
GP Margin 100.0%
EBIT Margin -3099.9%
EBITDA Margin -3099.9%
Operating Margin -3099.9%
Pretax Margin -4987.3%
Cont. Ops Margin -4658.6%
Net Margin -4658.6%
Bottom Line Margin -4658.6%

Liquidity Ratios

Ratio Value
Current Ratio 8.65
Quick Ratio 8.65
Solvency Ratio -0.308
Cash Ratio 8.38

Valuation Ratios

Ratio Value
Price/Earnings
-1.44
Hist. avg: 3.9
Peers avg: 32.2
PEG Ratio -0.02
Forward PEG -0.02
Price/Book -1.48
Price/Sales 66.95
Price/FCF -2.36
Price/Op Cash Flow -2.53

Debt Ratios

Ratio Value
Debt/Assets 0.0428
Debt/Equity -0.1004
Debt/Capital -0.1116
Long-Term Debt/Capital 0.0000
Financial Leverage -2.35

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.02
Operating Cash Flow Ratio -4.950
Operating Cash Flow/Sales -2643.6%
Free Cash Flow/Operating Cash Flow 107.4%

Coverage Ratios

Ratio Value
Debt Service Coverage -18.67
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -17.81
Operating Cash Flow Coverage -5.83
Capital Expenditure Coverage -13.56
Dividend + Capital Expenditure Coverage -13.56

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.11
EPS -5.017
Debt/Share 0.4880
Cash/Share 4.82
Book Value/Share -4.86
Tangible BV/Share -6.71
Equity/Share -4.86
Operating Cash Flow/Share -2.847
Capital Expenditure/Share 0.210
FCF/Share -3.057

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.934
Earnings Before Tax/EBIT 1.609
Price/Fair Value -1.48
Debt/Market Cap 0.0222
Effective Tax Rate 6.6%
Enterprise Value Multiple -0.86